Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

Autor: Kuryk, Lukasz, Mathlouthi, Sara, Wieczorek, Magdalena, Gad, Beata, Rinner, Beate, Malfanti, Alessio, Mastrotto, Francesca, Salmaso, Stefano, Caliceti, Paolo, Garofalo, Mariangela
Zdroj: In European Journal of Pharmaceutics and Biopharmaceutics June 2024 199
Databáze: ScienceDirect